◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksM › MAK

Maternus-Kliniken Aktiengesellschaft (MAK) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Care Facilities · DATA UPDATED 2026-08-16

Maternus-Kliniken Aktiengesellschaft (MAK) operates in the Medical Care Facilities industry and is headquartered in Berlin, Germany with about 1,860 employees. Its market capitalization is roughly €20 million. In the fiscal year ended 2025-12-31, MAK reported €118M in revenue and (€14M) in net income.

Maternus-Kliniken Aktiengesellschaft operates senior citizen homes, care facilities, rehabilitation clinics in Germany. The company also provides specialized services in geriatric care and rehabilitation medicine.

Interactive charts & full statements →

MAK Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue€118M€114M€102M€107M
Gross Profit€104M€99M€87M€87M
Operating Income (EBIT)(€6M)(€4M)(€9M)(€10M)
Net Income(€14M)(€13M)(€14M)(€14M)

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MAK Free Cash Flow History

MAK Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets€150M€140M€154M€153M
Total Liabilities€230M€207M€208M€193M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MAK viewer.

Other Companies in Medical Care Facilities

← MAJEAll “M” companiesMAKO →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.